Chris Storgard - 01 May 2025 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Role: Chief Medical Officer
Signature: /s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol: DSGN
Transactions as of: 01 May 2025
Net transactions value: $0
Form type: 4
Filing time: 23 May 2025, 16:26:36 UTC
Previous filing: 23 May 2025
Next filing: 05 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Storgard Chris	Chief Medical Officer	C/O DESIGN THERAPEUTICS, INC., 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD	/s/ Mustapha Parekh, Attorney-in-Fact	23 May 2025	0001674703

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DSGN	Stock Option (right to buy)	Award	$0	+400,000		$0.000000	400,000	01 May 2025	Common Stock	400,000	$4.71	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option will vest as follows: 25% of the shares will vest on April 16, 2026 and the balance of the shares will vest in equal monthly installments thereafter over the following 36 months.